Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Embrace Varnish
- Development stage
- Unknown
- Lead developer
- Pulpdent
- Modality
- Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
**Embrace Varnish** is a Pulpdent resin-based topical dental varnish containing 5% sodium fluoride, equivalent to 22,600 ppm fluoride, with the proprietary CXP xylitol-coated calcium and phosphate delivery system. Applied as a thin film to tooth surfaces, saliva dissolves the xylitol coating and releases calcium and phosphate ions alongside fluoride; these ions support fluorapatite formation on enamel and dentin. The varnish provides sustained ion release for at least four hours, helps occlude dentinal tubules to treat dental hypersensitivity, fills superficial non-carious enamel lesions, and is used for dental caries prevention.
- Brand names
- Embrace Varnish
Beyond the preview
Go deeper on Embrace Varnish.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Embrace Varnish.